Skip to main content

Tom Angelo Joins School to Support Educational Research and Innovation

August 25, 2015

Thomas Angelo, Ed.D., has been appointed as a clinical professor of educational innovation and research in the Division of Practice Advancement and Clinical Education and director of educator development in the Academy. In this dual appointment, Angelo will develop hands-on workshops and other resources to support the School’s reengineered Pharm.D. curriculum, as well as coteaching some courses. He will also collaborate on educational research and assessment projects and mentor junior faculty, fellows and graduate students. “The hiring of Dr. Angelo serves as a prominent symbol of the School’s commitment to the pursuit of excellence and innovation in student learning,” said … Continued


Yanguang Cao Joins DPET Faculty as Assistant Professor

August 24, 2015

Yanguang “Carter” Cao, Ph.D., has joined the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy as of August 1. Cao comes to UNC from the State University of New York at Buffalo. “Dr. Cao’s dedication to research, his ability to be an effective teacher and his many outstanding personal attributes bode well for success here at the School,” says Angela Kashuba, Pharm.D., DPET chair and the John and Deborah McNeill Jr. Distinguished Professor. “He is a promising young investigator in the quantitative sciences, and he will be a highly valuable addition to our faculty at … Continued


Daniel Crona to Join DPET as Assistant Professor

August 18, 2015

Daniel Crona, Pharm.D., Ph.D., will join the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy as a tenure-track assistant professor on October 1. Crona will also have an appointment at the North Carolina Cancer Hospital where he will work as a clinical pharmacist specialist in genitourinary oncology. Crona’s research has focused on identifying and validating novel genetic variants associated with survival in patients with advanced or metastatic kidney cancer. Discovery of these variants could help health-care providers identify the patients that would benefit most from different oral chemotherapeutics. “Dan Crona is a highly promising young … Continued


$2.4 Million NIH Grant to Support Study of Tumor Penetration by Nanogel

August 10, 2015

UNC Eshelman School of Pharmacy nanomedicine researchers received a five-year grant to study whether the properties of certain nanomaterials would improve the delivery of cancer treatments to their tumor targets. The $2.42 million, five-year grant from the National Institutes of Health will fund a collaborative research effort between scientists at the UNC Lineberger Comprehensive Cancer Center and UNC Eshelman School of Pharmacy as well as at the University of Nebraska Medical Center. The researchers plan to study whether the use of a drug-carrying nanoparticle material they’ve designed called the core-shell nanogel can better penetrate tumors. “The whole idea of this … Continued


Jeffrey Aubé Joins Division of Chemical Biology and Medicinal Chemistry

August 3, 2015

Jeffrey Aubé, PhD, has traded Kansas blue for Carolina blue and joined the UNC Eshelman School of Pharmacy as a Fred Eshelman Distinguished Professor in the School’s Division of Chemical Biology and Medicinal Chemistry. “Jeff Aubé is an extraordinarily accomplished scientist with an international reputation for conducting ground-breaking research,” says Dean Bob Blouin, Pharm.D. “He is an outstanding educator, a consensus builder and a charismatic leader in the professional world of the pharmaceutical sciences.” Aubé’s research program in organic chemistry encompasses organic synthesis methodology and natural product total synthesis focusing on alkaloids. One of his group’s signature accomplishments is the … Continued


School Receives T32 Grant for Training Program in Cancer Nanotechnology

July 13, 2015

A federal grant awarded to the University of North Carolina at Chapel Hill will help grow the workforce of scientists and doctors working in cancer nanotechnology through the launch of a new postdoctoral training program. The University has received a $1.8 million, five-year grant from the National Institutes of Health to create a postdoctoral training program within the UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery researchers. The program will be run in collaboration with the Carolina Institute for Nanomedicine, the Carolina Center for Cancer Nanotechnology Excellence and the UNC Lineberger Comprehensive Cancer Center. The award, a … Continued


Shrewsbury Reappointed to USP Compounding Committee

June 25, 2015

Robert Shrewsbury, PhD, has been elected to serve a second five-year term on the Compounding Expert Committee of the United States Pharmacopeial Convention. The USP publishes the U.S. Pharmacopeia and National Formulary, which sets standards for prescription and over-the-counter drugs and other health-care products sold in the United States and in many other countries. Shrewsbury is an associate professor in the Division of Practice Advancement and Clinical Education at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. He has served as an expert on the USP Compounding Committee since 2010. Since he joined … Continued


Eshelman Institute for Innovation Launches

June 2, 2015

The Eshelman Institute for Innovation at the University of North Carolina at Chapel Hill — created by a historic $100 million gift to the UNC Eshelman School of Pharmacy in December — has officially launched. The Eshelman Institute aims to inspire a culture of innovation where imagination and creative solutions accelerate change in education, research and health care. The institute provides a mechanism for faculty, staff, and students to seek funding for bold ideas and also provides opportunities to educate and train students and postdoctoral fellows; foster collaboration, creativity, and innovation; and stimulate commercialization of intellectual property and entrepreneurial development. The institute … Continued


School Wins TBJ Life Sciences Award for Chemo-Cleaning Wipe

May 22, 2015

The UNC Eshelman School of Pharmacy received a 2015 BDO Life Sciences Award from the Triangle Business Journal on May 21 in the category of outstanding research university. The School won for the work of William Zamboni, PharmD, PhD, and Stephen Eckel, PharmD, MHA, in developing wipe kits that detect and remove hazardous residue left on surfaces from the preparation of chemotherapy drugs. Eckel, a leading expert on the issue of chemotherapy contamination in the workplace, says studies have found that people who prepare and administer chemotherapy drugs are at risk of developing complications from exposure to those drugs. Despite … Continued


Kashuba to Play Role in New UNC-GSK Partnership to Accelerate Search for HIV Cure

May 11, 2015

The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and health-care company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS. This unique public-private partnership will redefine the traditional way of conducting research and create a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue. The HIV Cure … Continued